Heritage Pharmaceuticals Acyclovir Tablets Recall: FDA Class III

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date

Product description

Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01. Packaged in 150 cc white HDPE bottle

Lot numbers, UPCs & expiration codes

Lot A120036, Exp DEC 2023

Where it was sold

What to do if you have this product

Compare the lot number and expiration date on your package with the codes above.
Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
If you have symptoms you think are related, contact your doctor. In an emergency call 911.
Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number: D-0367-2021
Classification: Class III
Status: Terminated
Recall initiated: Apr 21, 2021
FDA report date: May 12, 2021
Quantity: 408 bottles
Recall type: Voluntary: Firm initiated
Recalling firm: Heritage Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-0367-2021, exactly as published.

Show all FDA fields

City: East Brunswick
State: NJ
Status: Terminated
Country: United States
Event ID: 87762
Address: 1 Tower Center Blvd Ste 1700
Code information: Lot A120036, Exp DEC 2023
Postal code: 08816-1145
Report date: May 12, 2021
Product type: Drugs
Recall number: D-0367-2021
Classification: Class III
Recalling firm: Heritage Pharmaceuticals Inc
Product quantity: 408 bottles
Termination date: Jun 9, 2022
Reason for recall: Labeling: Incorrect or Missing Lot and/or Exp Date
Voluntary / mandated: Voluntary: Firm initiated
Product description: Acyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., East Brunswick, NJ 08816, NDC 23155-227-01. Packaged in 150 cc white HDPE bottle
Distribution pattern: OH
Recall initiation date: Apr 21, 2021
Initial firm notification: Letter
Center classification date: May 6, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0367-2021, published May 12, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: Oct 2, 2026. Content last changed: Oct 2, 2026.

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

Heritage Pharmaceuticals Acyclovir Tablets Recall

Summary